Fig. 3From: A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic controlFibrin clot final turbidity and lysis time in controls and patients with type 1 diabetes (T1D) at baseline and when receiving aspirin 75 mg or 300 mg once daily (OD). Bars represent mean ± SD. P values are shown for within-participant comparisons (left) and between groups (right)Back to article page